I think all we are saying is. Trials need to be completed in order for us to be satisfied with the science. I think Aligning with FDA protocols is a safe argument
- Forums
- ASX - By Stock
- MSB
- Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse Bearish
MSB
mesoblast limited
Add to My Watchlist
6.37%
!
$2.35
Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse Bearish, page-48
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
